DI MARCO, Roberto Maria Antonio
 Distribuzione geografica
Continente #
NA - Nord America 3.715
AS - Asia 2.427
EU - Europa 1.621
SA - Sud America 465
AF - Africa 154
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.393
Nazione #
US - Stati Uniti d'America 3.572
SG - Singapore 1.009
CN - Cina 816
IT - Italia 541
BR - Brasile 430
IE - Irlanda 352
UA - Ucraina 278
KR - Corea 224
HK - Hong Kong 213
CA - Canada 120
DE - Germania 98
CI - Costa d'Avorio 91
RU - Federazione Russa 83
SE - Svezia 70
GB - Regno Unito 50
IN - India 34
SN - Senegal 34
AT - Austria 22
FR - Francia 22
VN - Vietnam 22
PL - Polonia 19
FI - Finlandia 18
TR - Turchia 18
NL - Olanda 17
BD - Bangladesh 16
MX - Messico 13
AR - Argentina 12
CH - Svizzera 12
BG - Bulgaria 11
UZ - Uzbekistan 11
IR - Iran 10
PK - Pakistan 10
IQ - Iraq 9
ZA - Sudafrica 9
GR - Grecia 8
AU - Australia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
JP - Giappone 6
BE - Belgio 5
EC - Ecuador 5
MA - Marocco 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
LB - Libano 4
MK - Macedonia 4
PE - Perù 4
DO - Repubblica Dominicana 3
ID - Indonesia 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
TN - Tunisia 3
AO - Angola 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
MY - Malesia 2
NG - Nigeria 2
PH - Filippine 2
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ES - Italia 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KI - Kiribati 1
KZ - Kazakistan 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.393
Città #
Santa Clara 876
Singapore 588
Hefei 412
Jacksonville 365
Dublin 352
Chandler 263
Seoul 222
Houston 211
Civitanova Marche 160
Boardman 153
Catania 148
Chicago 134
Nanjing 99
Cambridge 95
Andover 94
Lawrence 94
Abidjan 91
Toronto 85
Beijing 79
Ashburn 74
Des Moines 45
San Mateo 45
Wilmington 43
Grafing 37
Dakar 34
Hebei 32
São Paulo 29
Los Angeles 27
Nanchang 27
Brooklyn 22
Ottawa 20
Campobasso 19
Jiaxing 18
Rio de Janeiro 17
Saint Petersburg 17
Tianjin 17
Shenyang 16
Changsha 14
Columbus 14
New York 14
The Dalles 14
Munich 13
Naples 13
Bremen 12
Rome 12
San Francisco 12
London 11
Moscow 11
Phoenix 11
Curitiba 10
Dong Ket 10
Hangzhou 10
Palermo 10
Warsaw 10
Maletto 9
Nuremberg 9
Salerno 9
Seattle 9
Turku 9
Vienna 9
Atlanta 8
Juiz de Fora 8
Augusta 7
Belo Horizonte 7
Brasília 7
Leawood 7
Milan 7
Mountain View 7
Mumbai 7
Lappeenranta 6
Manchester 6
Montreal 6
Norwalk 6
Porto Alegre 6
Stockholm 6
Tokyo 6
Washington 6
Ardabil 5
Brussels 5
Chennai 5
Dallas 5
Frankfurt Am Main 5
Guarulhos 5
Istanbul 5
Johannesburg 5
Kunming 5
Padova 5
Paris 5
Tashkent 5
Amsterdam 4
Ankara 4
Baghdad 4
Baku 4
Caruaru 4
Caxias do Sul 4
Chiaramonte Gulfi 4
Council Bluffs 4
Dhaka 4
Goiânia 4
Ho Chi Minh City 4
Totale 5.532
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 307
N-acetylcysteine causes analgesia by activating group II metabotropic glutamate receptors 282
Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. 259
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 109
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 85
Expression of the oas gene family is highly modulated in subjects affected by juvenile dermatomyositis, resembling an immune response to a dsRNA virus infection 82
Validità dell’autotrapianto di milza nella difesa dalle infezioni batteriche. Ricerche sperimentali 80
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 79
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 77
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 75
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 74
Immunomodulatory properties of cefaclor: In vivo effect on cytokines release and lymphoprolipherative response on rat 73
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 73
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 72
Preliminary in vitro studies on Corynebacterium urealyticum pathogenetic mechanisms, a possible candidate for chronic idiopathic prostatitis? 71
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: FC construct 69
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 68
DATI PRELIMINARI SULLE MODIFICAZIONI DI ALCUNI PARAMETRI DEL SISTEMA IMMUNITARIO UMANO INDOTTE DAL TRATTAMENTO CON CEFACLOR 68
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 68
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 67
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 67
Dati preliminari sulle modificazioni di alcuni parametri del sistema immunitario umano indotte dal trattamento con cefaclor 66
In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse 65
FK-506 prevents diabetes in diabetes-prone BB/Wor rats 65
Probiotics:overview of microbiological and immunological characteristics 65
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 65
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 65
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse 64
Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution 64
Expression of DNA methylation genes in secondary progressive multiple sclerosis 63
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 63
Sodium fusidate in Guillain-Barre syndrome: a case report 62
Therapeutic effects of single administration of Cyclophosphamide in rat experimental autoimmune neuritis, a pre-clinical model of autoimmune peripheral neuropathies 62
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14 62
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis 61
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock 61
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 60
Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties 60
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 60
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 60
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 59
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 59
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 59
Protection from concanavalin A (Con A) induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate 58
Glycopeptide- and carbohydrate-based synthetic vaccines for cancer immunotherapy 58
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 57
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-y 57
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 57
Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies 57
Protection from Experimental Autoimmune Thyroiditis in CBA Mice with the Novel Immunosuppressant Deoxyspergualin 57
THE EFFECT OF CEFEPIME ON SOME IMMUNE PARAMETERS IN-VITRO - LACK OF INTERFERENCE WITH MITOGEN-INDUCED LYMPHOPROLIFERATION, IMMUNOGLOBULIN-SYNTHESIS, IFN-GAMMA AND IL-2 SECRETION AND IL-2 RECEPTOR EXPRESSION 57
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? 56
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 55
Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody 55
Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin 55
The Effects of Deoxyspergualin on the Development of Diabetes in Diabetes‐Prone BB Rats 54
Increased serum levels of interleukin-18 in patients with multiple sclerosis 54
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism 53
A Potential "Vitaminic Strategy" against Caries and Halitosis 53
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse 51
Short-term treatment of relapsing remitting Multiple sclerosis patients with interferon (INF)-beta 1B transiently increases the blood levels of Interleukine (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta IL-2, IL-4 and Tumor necrosis factors-alfa 51
Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model 49
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency 48
Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis 48
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 48
Blood levels of transforming growth factor-beta 1 (TGF-beta 1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta 1b) 47
Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor 47
Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats 47
Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice 47
Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat 46
Synergistic effect of deoxyspergualin (DPS) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats 45
Effetti della somministrazione di un enterovaccino nella profilassi delle cistiti e vaginiti ricorrenti 45
The Effects of Thymopentin on the Development of SLE‐Like Syndrome in the MRL/lpr‐lpr Mouse 45
Epidemiology of antibiotic resistance in human isolates of Enterobacteriaceae in Sicily 44
Correlation of the persistance or eradication of Porphyromonas gingivalis with pochet depth reduction in the treatment of periodontal Disease 44
Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat 43
INCREASE OF SOLUBLE CD30 (SCD30) AND EOSINOPHIL COUNT IN MYELOMA PATIENTS TREATED WITH A REGIMEN INCLUDING THALIDOMIDE 43
Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats 43
The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells 43
COMPOSIZIONE PER PREVENIRE O TRATTARE LA SINDROME DELL'OVAIO POLICISTICO E LA SINTOMATOLOGIA CORRELATA 42
INCREASED RATE OF SURVIVAL IN STREPTOCOCCUS PNEUMONIAE-INFECTED RATS TREATED WITH THE NEW IMMUNOMODULATOR PIDOTIMOD 42
Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice 42
Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. 42
In Vitro and In Vivo Biological Activity of Berberine Chloride against Uropathogenic E. coli Strains Using Galleria mellonella as a Host Model 42
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 41
Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice 41
Upregulated expression of macrophage migration inhibitory factor, its analogue d-dopachrome tautomerase, and the cd44 receptor in peripheral cd4 t cells from clinically isolated syndrome patients with rapid conversion to clinical defined multiple sclerosis 41
Akkermansia muciniphila: new insights into resistance to gastrointestinal stress, adhesion, and protein interaction with human mucins through optimised in vitro trials and bioinformatics tools 40
Neopterin: a potential marker in chronic peripheral arterial disease 40
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment 38
Emerging Evidence on Tenebrio molitor Immunity: A Focus on Gene Expression Involved in Microbial Infection for Host-Pathogen Interaction Studies 37
COMPOSITION FOR THE PREVENTION AND TREATMENT OF ACUTE AND RECURRENT URINARY TRACT INFECTIONS 37
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review 37
LimpiAD foam and the potential control of the pressure ulcers onset 36
Efficacy and Microbiota Modulation Induced by LimpiAL 2.5%, a New Medical Device for the Inverse Psoriasis Treatment 36
Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet 36
The new invasive mosquito species Aedes koreicus as vector-borne diseases in the European area, a focus on Italian region: What we know from the scientific literature 35
Investigation of Healthcare-Acquired Infections and Antimicrobial Resistance in an Italian Hematology Department before and during the COVID-19 Pandemic 35
Symbiotic Wolbachia in mosquitoes and its role in reducing the transmission of mosquito-borne diseases: updates and prospects 35
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis 35
Totale 6.202
Categoria #
all - tutte 33.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 39 75 4 141 13 73 2 73 2 119 32
2021/2022664 82 96 3 13 104 9 99 13 64 0 21 160
2022/20231.208 96 29 13 75 86 181 5 371 274 14 45 19
2023/2024438 19 62 18 40 16 100 5 35 2 17 79 45
2024/20253.870 7 275 116 471 894 295 200 144 318 364 311 475
2025/2026784 623 161 0 0 0 0 0 0 0 0 0 0
Totale 8.736